JP2017525668A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525668A5
JP2017525668A5 JP2016575768A JP2016575768A JP2017525668A5 JP 2017525668 A5 JP2017525668 A5 JP 2017525668A5 JP 2016575768 A JP2016575768 A JP 2016575768A JP 2016575768 A JP2016575768 A JP 2016575768A JP 2017525668 A5 JP2017525668 A5 JP 2017525668A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
acceptable salt
compound
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016575768A
Other languages
English (en)
Japanese (ja)
Other versions
JP6663866B2 (ja
JP2017525668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/038345 external-priority patent/WO2016003917A1/en
Publication of JP2017525668A publication Critical patent/JP2017525668A/ja
Publication of JP2017525668A5 publication Critical patent/JP2017525668A5/ja
Application granted granted Critical
Publication of JP6663866B2 publication Critical patent/JP6663866B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016575768A 2014-07-03 2015-06-29 リジン特異的なデメチラーゼ−1の阻害剤 Expired - Fee Related JP6663866B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462020886P 2014-07-03 2014-07-03
US62/020,886 2014-07-03
PCT/US2015/038345 WO2016003917A1 (en) 2014-07-03 2015-06-29 Inhibitors of lysine specific demethylase-1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019029856A Division JP6768857B2 (ja) 2014-07-03 2019-02-21 リジン特異的なデメチラーゼ−1の阻害剤

Publications (3)

Publication Number Publication Date
JP2017525668A JP2017525668A (ja) 2017-09-07
JP2017525668A5 true JP2017525668A5 (show.php) 2018-05-31
JP6663866B2 JP6663866B2 (ja) 2020-03-13

Family

ID=55019883

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016575768A Expired - Fee Related JP6663866B2 (ja) 2014-07-03 2015-06-29 リジン特異的なデメチラーゼ−1の阻害剤
JP2019029856A Expired - Fee Related JP6768857B2 (ja) 2014-07-03 2019-02-21 リジン特異的なデメチラーゼ−1の阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019029856A Expired - Fee Related JP6768857B2 (ja) 2014-07-03 2019-02-21 リジン特異的なデメチラーゼ−1の阻害剤

Country Status (29)

Country Link
US (3) US9902719B2 (show.php)
EP (2) EP3164380B1 (show.php)
JP (2) JP6663866B2 (show.php)
KR (1) KR102475498B1 (show.php)
CN (2) CN108530424B (show.php)
AU (1) AU2015284383B2 (show.php)
BR (1) BR112017000043A2 (show.php)
CA (1) CA2954049A1 (show.php)
CL (1) CL2016003422A1 (show.php)
CO (1) CO2017000549A2 (show.php)
CY (1) CY1125127T1 (show.php)
DK (2) DK3164380T3 (show.php)
EA (2) EA033698B1 (show.php)
EC (1) ECSP17006821A (show.php)
ES (2) ES2948782T3 (show.php)
FI (1) FI3511319T3 (show.php)
HR (2) HRP20220414T1 (show.php)
HU (2) HUE062558T2 (show.php)
IL (2) IL249881B (show.php)
LT (2) LT3511319T (show.php)
MX (2) MX376207B (show.php)
PL (2) PL3511319T3 (show.php)
PT (2) PT3164380T (show.php)
RS (2) RS64423B1 (show.php)
SA (1) SA517380651B1 (show.php)
SG (2) SG10201802501RA (show.php)
SI (2) SI3511319T1 (show.php)
SM (2) SMT202200136T1 (show.php)
WO (1) WO2016003917A1 (show.php)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180284095A1 (en) 2015-06-12 2018-10-04 Oryzon Genomics, S.A. Biomarkers associated with lsd1 inhibitors and uses thereof
WO2017013061A1 (en) 2015-07-17 2017-01-26 Oryzon Genomics, S.A. Biomarkers associated with lsd1 inhibitors and uses thereof
WO2017157825A1 (en) 2016-03-15 2017-09-21 F. Hoffmann-La Roche Ag Combinations of lsd1 inhibitors for use in the treatment of solid tumors
WO2017158136A1 (en) 2016-03-16 2017-09-21 Oryzon Genomics, S.A. Methods to determine kdm1a target engagement and chemoprobes useful therefor
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US20190256930A1 (en) 2016-11-03 2019-08-22 Oryzon Genomics, S.A. Biomarkers for determining responsiveness to lsd1 inhibitors
RS66336B1 (sr) 2017-08-03 2025-01-31 Oryzon Genomics Sa Postupci za lečenje bihejvioralnih poremećaja
PL3833670T3 (pl) * 2018-08-10 2024-08-19 Navire Pharma, Inc. Pochodne 6-(4-amino-3-metylo-2-oksa-8-azaspiro[4.5]dekan-8-ylo)-3-(2,3-dichlorofenylo)-2-metylopirymidyn-4(3h)-onu oraz powiązane związki jako inhibitory ptpn11 (shp2) do leczenia raka
JP7532386B2 (ja) 2019-02-01 2024-08-13 ハンミ ファーマシューティカルズ カンパニー リミテッド イミダゾピリジン誘導体化合物及びその用途
CN113365996B (zh) * 2019-02-01 2024-09-03 韩美药品株式会社 咪唑吡啶衍生化合物以及药物组成物
CN113613653A (zh) 2019-03-20 2021-11-05 奥莱松基因组股份有限公司 治疗边缘型人格障碍的方法
CN120837494A (zh) 2019-03-20 2025-10-28 奥莱松基因组股份有限公司 使用kdm1a抑制剂如化合物伐菲德司他治疗注意缺陷多动症的方法
EP3994280A1 (en) 2019-07-05 2022-05-11 Oryzon Genomics, S.A. Biomarkers and methods for personalized treatment of small cell lung cancer using kdm1a inhibitors
US11360505B2 (en) 2020-02-11 2022-06-14 Simmonds Precision Products, Inc. Distributed network time synchronization
CN114105950B (zh) * 2020-08-31 2022-09-06 南京明德新药研发有限公司 吡唑类化合物及其应用
CN117015540A (zh) * 2021-03-11 2023-11-07 南京明德新药研发有限公司 噻吩类化合物及其应用
CN117062813A (zh) * 2021-03-24 2023-11-14 四川汇宇制药股份有限公司 一种多环化合物及其应用
WO2022214303A1 (en) 2021-04-08 2022-10-13 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors for treating myeloid cancers
CN116102533A (zh) * 2021-11-11 2023-05-12 中国科学院上海药物研究所 一种芳杂环类化合物及其应用
JP2025516647A (ja) 2022-05-09 2025-05-30 オリゾン・ゲノミクス・ソシエダッド・アノニマ Lsd1阻害薬を用いる悪性末梢神経鞘腫(mpnst)の治療法
US20250295660A1 (en) 2022-05-09 2025-09-25 Oryzon Genomics, S.A. Methods of treating nf1-mutant tumors using lsd1 inhibitors
WO2024110649A1 (en) 2022-11-24 2024-05-30 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors and menin inhibitors for treating cancer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
WO2002026718A2 (en) * 2000-09-29 2002-04-04 Millennium Pharmaceutical, Inc. Bicyclic pyrimidin-4-one based inhibitors of factor xa
US7365069B2 (en) * 2002-04-10 2008-04-29 Bexel Pharmaceuticals Inc. Pyrimidone derivatives
JP2005170792A (ja) * 2002-11-22 2005-06-30 Mitsubishi Pharma Corp L−プロリン誘導体およびその医薬としての用途。
CA2548918C (en) 2003-12-11 2013-05-21 Mitsubishi Pharma Corporation Alpha-amino acid derivatives and use thereof as medicines
WO2006073167A1 (ja) * 2005-01-07 2006-07-13 Ono Pharmaceutical Co., Ltd. ピロリジン誘導体
PL372332A1 (pl) * 2005-01-19 2006-07-24 ADAMED Sp.z o.o. Nowe związki, pochodne kwasu 3-fenylopropionowego
WO2006129181A2 (en) * 2005-06-03 2006-12-07 Orchid Research Laboratories Limited Preparation of 4-pyrimidone derivatives for treating inflammatory diseases
SI1924561T1 (sl) * 2005-09-01 2013-02-28 Eli Lilly And Company 6-arilalkilamino-2,3,4,5-tetrahidro-1h-benzo(d)azepini kot agonisti 5-ht2c receptorja
JP2007197324A (ja) 2006-01-23 2007-08-09 Toray Ind Inc 2,4,5−置換−1,3−アゾール誘導体
US7652018B2 (en) 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
PE20081803A1 (es) 2007-03-09 2008-12-11 Wyeth Corp Sintesis y caracterizacion de la forma ii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo
CL2008002793A1 (es) * 2007-09-20 2009-09-04 Cgi Pharmaceuticals Inc Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
WO2009132310A1 (en) * 2008-04-25 2009-10-29 Wisconsin Alumni Research Foundation Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
US20130096160A1 (en) * 2010-04-14 2013-04-18 Secretary, Department Of Health And Human Services Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production
WO2012009475A1 (en) * 2010-07-14 2012-01-19 Oregon Health & Science University Methods of treating cancer with inhibition of lysine-specific demethylase 1
US9388196B2 (en) 2012-03-06 2016-07-12 Lupin Limited Thiazole derivatives as alpha 7 nAChR modulators
LT3080100T (lt) * 2013-12-11 2023-02-27 Celgene Quanticel Research, Inc. Lizinui specifinės demetilazės-1 inhibitoriai
EP3105229A4 (en) * 2014-02-14 2017-12-20 The University of British Columbia Human androgen receptor dna-binding domain (dbd) compounds as therapeutics and methods for their use
RS62874B1 (sr) * 2014-05-01 2022-02-28 Celgene Quanticel Research Inc Inhibitori lizin specifične demetilaze-1
FR3020945B1 (fr) 2014-05-16 2016-05-06 Oreal Composition pour colorer les fibres keratiniques comprenant une base d'oxydation et un coupleur heteroaryle particulier
CN106660987B (zh) * 2014-06-27 2020-11-06 赛尔基因昆蒂赛尔研究公司 赖氨酸特异性脱甲基酶-1的抑制剂
ES2905280T3 (es) * 2014-07-03 2022-04-07 Celgene Quanticel Res Inc Inhibidores de la desmetilasa 1 específica de lisina

Similar Documents

Publication Publication Date Title
JP2017525668A5 (show.php)
JP2017514830A5 (show.php)
JP2017521407A5 (show.php)
JP2017519781A5 (show.php)
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
JP2010526129A5 (show.php)
JP2017502940A5 (show.php)
HRP20180199T1 (hr) Urea derivati ili njihove farmakološki prihvatljive soli korisni kao agonisti formil peptidnom receptoru-sličnom i (fprl-1)
HRP20220414T1 (hr) Inhibitori lizin specifične demetilaze-1
JP2012501312A5 (show.php)
AU2013355054B2 (en) Diazole lactams
JP2020502092A5 (show.php)
JP2018527295A5 (show.php)
JP2017533968A5 (show.php)
JP2009542716A5 (show.php)
JP2011510929A5 (show.php)
AU2014298051A1 (en) Novel quinazolinones as bromodomain inhibitors
DK2935227T3 (en) DIAZOLAMIDES AS CCR1 RECEPTOR ANTAGONISTS
JP2011505347A5 (show.php)
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen
KR20220083775A (ko) Pd-l1 질환의 치료를 위한 헤테로아릴-바이페닐 아민
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
JP2011513475A5 (show.php)
RU2013146659A (ru) Способы лечения рака
JP2017510595A5 (show.php)